Medtronic Stent Approved to Treat Coronary Artery Disease

Including people with diabetes

TUESDAY, Feb. 21 (HealthDay News) -- Medtronic's Resolute Integrity Drug-Eluting Stent (DES) has been approved by the U.S. Food and Drug Administration for people with coronary artery disease (CAD), the Minneapolis-based company said in a news release.

A stent is a hollow mesh tube used to prop open a narrowed coronary vessel. Medtronic's Resolute Integrity DES is made from a drug-coated polymer material and resembles a flexible spring.

The device performed strongly in clinical studies, including among people with diabetes, a common contributor to CAD, Medtronic said.

CAD is the leading cause of death in the United States, killing almost 500,000 people annually, the company said.

More information

Medline Plus has more about coronary artery disease.

Copyright © 2012 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles

What internal motivators drive RNs to pursue a BSN?
Nursing2014 , October 2014
Free access will expire on November 24, 2014.


Breast Cancer Risk Assessment in Primary Care
MCN, The American Journal of Maternal/Child Nursing, September/October 2014
Free access will expire on November 10, 2014.


Nurses spurring innovation
Nursing Management, October 2014
Free access will expire on November 10, 2014.


More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events